HCV and HIV Coinfection
IL28B Polymorphisms as a Predic ...
Hepatitis C virus (HCV) is the most common cause of chronic liver disease in the United States. There are more than 170 million cases worldwide, and ...
Hepatitis B Genotypes: Role of ...
Hepatitis B viral genotypes influence natural history, with genotype Cmore likely to develop hepatocellular carcinoma than genotype B, thus influenc ...
HCV Response-Guided Therapy: Sh ...
The treatment of chronic HCV has traditionally been for a fixed duration based on genotype. We now recognize that patients respond to treatment alon ...
Extrahepatic Manifestations of ...
Hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is a leading cause of chronic liver disease worldwide. Ext ...
Ribavirin: How Does it Work and ...
Ribavirin is a synthetic guanosine analogue, which acts against hepatitis C virus (HCV) through several mechanisms that include 1) immune modulation ...
Combination Therapy for Chronic ...
Hepatitis B infection remains a major public health problem globally and in the United States, with significant use of healthcare resources. Several ...
Update on the Risk of Hepatocel ...
Chronic hepatitis B virus infection is an important cause of liver-related morbidity and mortality, with hepatocellular carcinoma being the most lif ...
New and Evolving Management Par ...
Hepatitis-C induced liver failure is the leading indication for liver transplantation in the United States, and the burden of hepatitis C virus (HCV ...
Update on Current Epidemiologic ...
Hepatitis C virus infection remains a leading cause of liver disease worldwide and is currently the principal reason for liver transplantation in th ...
Update on the Management of Ped ...
A primary challenge in the management of pediatric chronic hepatitis B (CHB) is the lack of established child-specific guidelines. Treatment decisio ...
Hepatitis C Virus and Innate Im ...
The innate immune response represents the first line of defense against hepatitis C virus (HCV) infection. The response is an early, coordinated eff ...
HCV Eradication: Implications f ...
Hepatitis C virus (HCV) is a leading cause of liver-related death worldwide. The evolution of hepatitis C therapy has made serologic eradication of ...
Current Management of HBV Antiv ...
Long-term administration of oral anti-hepatitis B virus (HBV) nucleoside or nucleotide analogues therapy (NUC) is the first-line treatment option fo ...
Hepatitis C Virus and End Stage ...
Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease in the world. It is particularly common in patients with end-stage ren ...
Management of Hepatitis C Antiv ...
Hepatitis C is one of the leading causes of liver disease in the United States, affecting more than 4 million individuals. The current treatment reg ...
Hepatitis B Vaccination: Curren ...
Hepatitis B virus (HBV) is the leading cause of chronic liver disease worldwide. Antiviral therapy for HBV is a safe and effective strategy for prev ...
Treatment of Chronic Hepatitis ...
The past standard-of-care (SOC) for treatment of the chronic hepatitis C virus (HCV) was the combination of peginterferon with ribavirin (P+R). Sus ...
Liver Transplantation for Hepat ...
Hepatitis C-positive liver transplantation (LT) patients present significant problems in post-transplant management. These patients are known to hav ...
The Role of Hepatic Steatosis i ...
Chronic hepatitis B (CHB) infection is a global public health burden, and is associated with substantial morbidity and mortality. Although viral fac ...
Hepatitis C Viral Kinetics in t ...
In the last decade, hepatitis C virus (HCV) kinetics has become an important clinical tool for the optimization of therapy with pegylated-interferon ...
HCV and HIV Coinfection
Chronic hepatitis C (CHC) is estimated to affect about 20% of the 34 million individuals currently living with HIV worldwide, with greater rates (~ ...
Post-transplant Management of H ...
Prior to the availability of effective posttransplant immunoprophylaxis, outcomes following liver transplant for hepatitis B-related liver disease w ...
Rational Guide to the Use of Er ...
Hepatitis C virus (HCV) infection is the leading reason for liver transplant in North America. Combination therapy with pegylated interferon and ri ...
Hepatocellular Carcinoma Survei ...
Hepatocellular carcinoma (HCC) is a malignant tumor arising primarily in cirrhotic livers as a consequence of chronic hepatitis B or C virus infecti ...
IL28B Polymorphisms and Treatme ...
Recently, single-nucleotide polymorphisms near the IL28B gene have been identified as important in predicting treatment response and spontaneous cle ...